Rapid-Acting Insulin Analogs Monitoring Bundle: A Prescriber's Guide
Evidence-based monitoring protocols for rapid-acting insulin analogs including lispro, aspart, and glulisine. Covers baseline labs, glycemic targets, hypoglycemia surveillance, and injection-site assessment for prescribers and pharmacists.
Read clinical review